NORGESIC FORTE

This brand name is authorized in United States

Active ingredients

The drug NORGESIC FORTE contains a combination of these active pharmaceutical ingredients (APIs):

1 Orphenadrine
UNII X0A40N8I4S - ORPHENADRINE CITRATE

Orphenadrine, which is a congener of diphenhydramine without sharing its soporific effect, is an anti-muscarinic agent. Orphenadrine is used as the hydrochloride in the symptomatic treatment of Parkinsonism.

Read about Orphenadrine
2 Acetylsalicylic acid
UNII R16CO5Y76E - ASPIRIN

Acetylsalicylic acid combines significant advantages such as strong anti-pyretic, analgesic and anti-inflammatory action, that is the measure of comparison with all the newer NSAIDs.

Read about Acetylsalicylic acid
3 Caffeine
UNII 3G6A5W338E - CAFFEINE

Caffeine is structurally related to the methylxanthines theophylline and theobromine. Caffeine’s main action is as a CNS stimulant.

Read about Caffeine

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
NORGESIC FORTE Tablet FDA, National Drug Code (US) MPI, US: SPL/Old

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: US FDA, National Drug Code Identifier(s): 50991-999

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.